[HTML][HTML] Osteolysis and cancer

D Goltzman - The Journal of clinical investigation, 2001 - Am Soc Clin Investig
The Journal of clinical investigation, 2001Am Soc Clin Investig
Schematic representation of tumor-cell induced osteolysis. A tumor cell may release soluble
mediators such as hormones (eg, PTHrP), eicosanoids, cytokines (eg, IL-6), or growth
factors (eg, TGF-α) that act on an osteoblastic stromal cell. The stromal cell produces
RANKL, which binds to its cognate receptor, RANK, expressed on osteoclast (Oc)
precursors. In the presence of M-CSF, which acts on its receptor, c-fms, RANKL can
enhance the formation of active osteoclasts that carry out bone resorption. Tumor cells have …
Schematic representation of tumor-cell induced osteolysis. A tumor cell may release soluble mediators such as hormones (eg, PTHrP), eicosanoids, cytokines (eg, IL-6), or growth factors (eg, TGF-α) that act on an osteoblastic stromal cell. The stromal cell produces RANKL, which binds to its cognate receptor, RANK, expressed on osteoclast (Oc) precursors. In the presence of M-CSF, which acts on its receptor, c-fms, RANKL can enhance the formation of active osteoclasts that carry out bone resorption. Tumor cells have also been occasionally reported to directly release sRANKL, a soluble form of RANKL. Additionally, proteases can be produced by tumor cells and facilitate their invasion of nonmineralized tissue.
The Journal of Clinical Investigation